These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10394675)

  • 1. Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana.
    McPartland JM; Pruitt PL
    Altern Ther Health Med; 1999 Jul; 5(4):57-62. PubMed ID: 10394675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical marijuana and its use by the immunocompromised.
    McPartland JM; Pruitt PL
    Altern Ther Health Med; 1997 May; 3(3):39-45. PubMed ID: 9141290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
    Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
    Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis and its derivatives: review of medical use.
    Leung L
    J Am Board Fam Med; 2011; 24(4):452-62. PubMed ID: 21737770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public health issue brief: medical marijuana: year end report-2004.
    Varma P
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-9. PubMed ID: 15765574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997.
    ElSohly MA; Ross SA; Mehmedic Z; Arafat R; Yi B; Banahan BF
    J Forensic Sci; 2000 Jan; 45(1):24-30. PubMed ID: 10641915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M; Bisaga A; Foltin RW
    Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the roles of cannabinoids in pain and other therapeutic indications: a review.
    Turcotte D; Le Dorze JA; Esfahani F; Frost E; Gomori A; Namaka M
    Expert Opin Pharmacother; 2010 Jan; 11(1):17-31. PubMed ID: 20001426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat models of prenatal and adolescent cannabis exposure.
    Dinieri JA; Hurd YL
    Methods Mol Biol; 2012; 829():231-42. PubMed ID: 22231817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
    Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
    Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies.
    Notcutt W; Price M; Miller R; Newport S; Phillips C; Simmons S; Sansom C
    Anaesthesia; 2004 May; 59(5):440-52. PubMed ID: 15096238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute psychotropic effects of oral cannabis extract with a defined content of Delta9-tetrahydrocannabinol (THC) in healthy volunteers.
    Kaufmann RM; Kraft B; Frey R; Winkler D; Weiszenbichler S; Bäcker C; Kasper S; Kress HG
    Pharmacopsychiatry; 2010 Jan; 43(1):24-32. PubMed ID: 20178093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of cannabis.
    Prescrire Int; 2011 Jan; 20(112):18-23. PubMed ID: 21462790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the pharmacological properties of Delta9-tetrahydrocannabinol (THC).
    Costa B
    Chem Biodivers; 2007 Aug; 4(8):1664-77. PubMed ID: 17712813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis.
    Prescrire Int; 2009 Oct; 18(103):226. PubMed ID: 19882800
    [No Abstract]   [Full Text] [Related]  

  • 17. Hair analysis for Delta9-tetrahydrocannabinolic acid A--new insights into the mechanism of drug incorporation of cannabinoids into hair.
    Auwärter V; Wohlfarth A; Traber J; Thieme D; Weinmann W
    Forensic Sci Int; 2010 Mar; 196(1-3):10-3. PubMed ID: 20129747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are oral cannabinoids safe and effective in refractory neuropathic pain?
    Attal N; Brasseur L; Guirimand D; Clermond-Gnamien S; Atlami S; Bouhassira D
    Eur J Pain; 2004 Apr; 8(2):173-7. PubMed ID: 14987627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis.
    Sarafian TA; Tashkin DP; Roth MD
    Toxicol Appl Pharmacol; 2001 Aug; 174(3):264-72. PubMed ID: 11485387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.